Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 17.173\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) O=C(/C=C/c1ccccc1)C1=C(O)C(=O)N(CCO)C1c1ccc2c(c1)OCO2
b) C/C=C(/C)C(=O)OC1Cc2c(ccc3ccc(=O)oc23)OC1(C)C
c) CCC1CCCCN1C(=O)c1cc2c(=O)n3cccc(C)c3nc2s1
Answer: c. CCC1CCCCN1C(=O)c1cc2c(=O)n3cccc(C)c3nc2s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC1CCCCN1C(=O)c1cc2c(=O)n3cccc(C)c3nc2s1
CCC1CCCCN1C(=O)c1cc2c(=O)n3cccc(C)c3nc2s1
5-(2-ethylpiperidine-1-carbonyl)-10-methyl-6-thia-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),4,8,10,12-pentaen-2-one